abbreviatioNs FBSS = failed-back surgery syndrome; SCS = spinal cord stimulation; TCS = tethered cord syndrome; VAS = visual analog scale. The authors present a patient with a lipomyelomeningocele and worsening back pain due to recurrent tethered cord syndrome. Because of the increased risk and unlikely improvement in symptoms with repeated surgical untethering, she was offered an alternative treatment with a trial of dorsal spinal cord stimulation. She had an excellent response to the percutaneous trial, and a permanent implant was placed, with good initial results. The authors review her case as well as the treatment options, indications, and outcomes for recurrent tethered cord syndrome.
P atients with tethered cords, particularly those with a lipomyelomeningocele, are at risk for recurrent tethering after a detethering procedure. These patients often present with worsening neurological deficits, particularly pain and urological dysfunction. 13, 14 Once symptoms develop, repeat surgery may not provide relief, and recurrent surgeries carry increased risk of additional postoperative neurological deficit without recovery from presenting symptoms. 11 Relief of pain is often the most important aspect of patient care in this population. Therefore, especially once complete incontinence has developed, repeat detethering is less beneficial due to the unlikelihood of improvement in symptoms. Spinal cord stimulation (SCS) addresses neuropathic pain without the risk of worsening neurological function due to mechanical manipulation of the neural elements, and therefore may be an appropriate treatment for patients with recurrent tethered cord. 8, 30, 34 case report
History and Examination
We present a patient with a history of a lipomyelomeningocele and worsening back pain due to a recurrent tethered cord. The lesion was first found when the patient was 12 years old, after multiple procedures for a left foot deformity as a child. She developed new back pain and a recurrent left foot deformity at that time, and underwent her first untethering procedure at another institution. She remained stable, with only residual left foot weakness and mild deformity until the age of 19 years, when she developed recurrent back pain, urinary incontinence, and new right foot numbness and weakness. She was evaluated by a neurologist for worsening left leg numbness, and an MRI sequence was obtained, which showed a recurrent tethered cord (Fig. 1) . Electromyography showed acute and chronic denervation of S-1 and S-2 on the left side, and urodynamics showed evidence of a neurogenic bladder.
Operation and Postoperative Course
The patient underwent a detethering procedure, with an incomplete resection of the tethering lesion due to extensive fibrosis around the placode/roots from the previous procedure (Fig. 2) . A patulous thecal reconstruction was made with a Durepair graft. She did have increased numbness of both feet and mild worsened weakness requiring admission to an inpatient rehabilitation unit postoperatively. She developed a CSF leak that required reexploration 1 week after surgery, which was repaired without complication. After 2 months, her legs had improved sensation and strength compared with her preoperative status, but she had no improvement in bowel/bladder function, and she had worsening recurrent back pain. Flexion/extension radiographs showed no evidence of postoperative insta-bility (Fig. 3) . She progressed over the next month, with new development of a right foot deformity and worsening pain and numbness in both lower extremities, and recurrent tethered cord syndrome (TCS) was diagnosed. The significant risks of additional neurological deficit with attempted repeat untethering, and the likely failure of longterm improvement, were discussed with the patient and her family.
Pain Evaluation, Nonsurgical Treatments, and Outcomes
Because the most disabling symptoms were her back and leg pain, the patient was referred to the pain management service. During their evaluation, she reported constant burning pain with radiation into the legs bilaterally, visual analog scale (VAS) Score 8-9/10. The patient experienced associated allodynia and hyperpathia of the lower extremities in a nondermatomal pattern. Because the symptoms were consistent with neurogenic pain, a conservative approach was attempted, with medical management including NSAIDs, neurontin, Cymbalta, and Percocet, along with physical therapy including a Transcutaneous Electrical Nerve Stimulation (TENS) unit, with minimal relief. Subsequently a caudal epidural steroid injection was performed with fluoroscopic guidance to avoid the risk of neurological injury with a lumbar approach, also providing minimal relief.
Trial and Implantation of SCS Device, and Outcome
Therefore a trial of SCS was offered. She underwent placement of percutaneous SCS trial leads at T-8, with significant relief (Fig. 4) , and subsequently a permanent stimulator was placed (Fig. 5 ). Her VAS score improved from a preoperative value of 8 to a 2 at her first postoperative visit, with further improvement at her 6-week followup, to a score of 1. She was able to ambulate without assistive devices, and returned to work at a retail clothing store. There was no improvement in her bowel or bladder function, but she was able to remain socially continent. She did have some recurrence of her pain at 10 months postimplantation, but was still significantly better than prior to surgery ( Table 1) . The allodynia and hyperpathia were also improved, and she was able to wear clothing and shoes, perform her activities of daily living, and continue with her work.
Discussion
Tethered cord syndrome is a constellation of symptoms including any combination of back and leg pain, bowel and bladder dysfunction, scoliosis, lower-extremity weakness, atrophy, and deformity. The tethering lesion may be simply a tight filum terminale, or a form of spinal dysraphism including split cord malformations, myelomeningocele, lipomyelomeningocele, dermal sinus tract, or caudal regression syndrome. Pain is the most common presenting symptom of TCS in school-age children and adults, 13, 14 although it is less commonly noted in younger patients. 4 This may be due to the inability of young children to articulate their pain. This pain worsens with flexion or vigorous physical activity particularly, affecting primarily the lower back, perineum, and/or the legs. Among all the symptoms, pain is the one most likely to be improved at the time of initial surgery, involving a success rate of 75%-89% in the adult patient. 13, 18, 22 Bladder dysfunction and orthopedic deformities are the least likely to resolve after untethering.
14 Unfortunately, patients with recurrent tethering have a much poorer prognosis, with most developing permanent neurological deficits and intractable pain.
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Spinal cord untethering specifically for lipomyelomeningocele is a well-accepted procedure, with current recommendations for untethering prior to symptom onset in the hopes of preventing or delaying neurological deterioration, which may include back and/or leg pain, weakness, numbness, paresthesias, and incontinence. 2, 11 Once neurological deficits develop, secondary abnormalities including atrophy, limb deformity, and scoliosis may also progress to chronic problems requiring further surgical intervention. Unfortunately surgical intervention, even prior to the onset of deficits, does not guarantee longterm success, and treatment after the onset of symptoms is associated with higher rates of permanent neurological deficits. 2, 6, 14 This is particularly true of patients with an asymmetrical tethering, as in our patient. 6, 11 Despite surgery, many patients will show progressive deterioration over time, and often require repeated procedures. Deterioration is thought to be due to multiple factors, including mechanical tension on neural elements, and ischemia due to hypoperfusion of the cord. 36 The success of subsequent surgeries diminishes in adult patients, with poor pain relief, partial recovery or stabilization of motor and sensory deficits, and the unlikelihood of improvement in bladder dysfunction. The risk of retethering also increases after an episode of recurrent tethering, leading to a no-win situation for these patients with complicated cases. 11 An alternative method to reduce traction on the neural elements without detethering is to shorten the spine by performing a vertebrectomy. This has been described as a useful technique to prevent further neurological deficit when correction of a deformity or anterior decompression is indicated. 1, 3, 5, 12, 16, 27, 28, 37 Congenital deformities may be secondary to a primary tethered cord (usually a myelomeningocele with a gibbus), and good success has been noted in these cases. 12, 16, 28 Primary spine shortening to treat recurrent tethered cord symptoms in patients without a spinal deformity would theoretically be possible, but would be significantly more invasive, with a higher risk of complications than the SCS procedure that we chose.
Mechanism of SCS Specific to TCS
Complex postoperative pain syndromes are difficult to treat with pharmacological and interventional pain treatments. One of the more invasive but effective treatments for chronic neuropathic pain is dorsal SCS. This technique delivers mild electrical signals to the epidural space just posterior to the spinal cord through one or more thin wires, called leads. An initial percutaneous trial is performed with leads connected to an external pulse generator that the patient carries for a few days to determine if the stimulation provides adequate relief, and no significant side effects. If the treatment is effective, a permanent internal system is then implanted. A stimulator paddle passed to the same level as the trial leads is used, and the extension wire is tunneled subcutaneously to a distal pocket created for the pulse generator (Fig. 6) . The neurostimulation from the electric signal causes paresthesia in the area of chronic pain. Anatomical changes in the spinal cord, for example TCS, may influence the exact level and location of electrode implantation.
The effectiveness of SCS in patients with chronic intractable neuropathic pain is well known and has been comprehensively described. 8 Intraoperative stimulation is the cornerstone of any successful procedure; patients should be able to perceive stimulation in the same areas where they feel pain. Therefore, patients must be awake, feel comfortable without any pain, and be fully cooperative to report this to the implant team during the placement of electrodes. 8, 23 The gate control theory proposed by Melzack theorized that the balance between large and small fibers in the dorsal horn of the spinal cord played a major role in the perception of pain. 25 This theory was the major foundation for the development of SCS. It was proposed that by stimulating A-beta fibers through neuromodulation, less pain signaling would be perceived by the patient. 20, 23 In a review article by Linderoth and Foreman, 24 they proposed that the reduction of neuropathic pain from SCS results from inhibition of the dorsal horn's wide dynamic range neurons.
More recently, other theories of SCS modulation of pain control have been proposed; SCS has been involved in decreasing the responsiveness of wide dynamic range cells in the dorsal horn of the spinal cord to peripheral stimuli. 7 Furthermore, SCS may produce enhanced release of g-aminobutyric acid and decreased release of glutamate at the dorsal horn, both contributing to decreased modulation of pain perception. 7 Acetylcholine has also been shown to be released with SCS and is associated with activation of the muscarinic M4 receptor. 7 In a review by Wu et al. in 2008, a spinal cord stimulator was shown to produce antidromic activation of sensory fibers and decreased sympathetic outflow as well as an increase in vasomotor center activity and release of neurohumoral factors when placed in patients with vascular disease.
indications for scs
The US FDA currently approves SCS for chronic pain from failed-back surgery syndrome (FBSS), intractable low-back pain, and chronic pain of the trunk and limbs. 7 The SCS technique has been used for the treatment of various conditions, including complex regional pain syndrome, 32, 34 FBSS, 31, 34 peripheral vascular disease, 10 neuropathic pain, 33 refractory angina, 10 and more recently, visceral pain, 17 including pelvic pain. 15 Outcome research has shown that SCS for FBSS is effective to improve quality of life, increase activities of daily living, 21 and reduce health care costs for the long run.
Failed-back surgery syndrome, also known as postlaminectomy syndrome, is chronic intractable back and/or leg pain that results in varying degrees of functional status limitation after spinal surgery. 19 Relevant to FBSS, the percentage of patients who report significant pain relief after a single-level fusion ranges from 40% to 80%, whereas after a 3-level fusion the percentage drops to 15%. 9 Krames et al. concluded that SCS for the chronic pain of FBSS may be more cost-effective, safer, and more appropriate than repeat surgery. 19 In regard to pain suppression, SCS was more effective than reoperation in randomized controlled trials. 29 In the PROCESS (Prospective Randomized Controlled Multicenter Trial of the Effectiveness of Spinal Cord Stimulation) report published by Kumar et al. in 2008, 21 wherein patients were randomized to either SCS or conventional medical management for FBSS, 42 of 52 patients randomized to SCS reported significant relief of leg pain and an improved quality of life at 6 months. Additionally, of the patients randomized to medical management, after 6 months, 30 of the 44 patients crossed over to the SCS treatment arm; at 24 months, the addition of SCS to conservative management continued to provide additional pain relief compared with conservative management alone.
The case study presented by Moens et al. 26 showed benefit from SCS in adults with chronic pain secondary to tethered cord. In our case we were also able to obtain significant pain coverage. However, we used 2 epidural leads placed at T-8. In the study by Moens et al., they reported successful paresthesia coverage with leads placed much lower in the vertebral column (T-12).
conclusions
Recurrent TCS causes severe disability in patients, with often severe neuropathic pain. Dorsal SCS is an effective treatment in patients with other etiologies of chronic neuropathic pain. Patients with a lipomyelomeningocele are at particularly high risk for recurrent tethering, with progression of symptoms and worsening neurological deficits after attempts at repeat surgical detethering.
Despite the anatomical abnormality of the spinal cord in TCS, neuromodulation is an effective therapeutic option to achieve pain relief. 26 The implantation of a spinal cord stimulator in a young patient with TCS as an effective treatment for refractory chronic neuropathic pain has not been described previously. In our case we had a very good short-term outcome in a young adult patient with chronic intractable neuropathic mediated pain secondary to recurrent tethered cord. Further evaluation of this technique as an alternative treatment for recurrent TCS will be required to determine long-term results and applicability in a larger pool of patients with tethered cord.
references

